Skip to main content

Table 1 Characteristics of 204 patients with locally recurrent nasopharyngeal carcinoma

From: A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients

Characteristic

All (n = 204)

LNN (n = 31)

Non-LNN (n = 173)

Sex

 Men

160 (78.4)

18 (58.1)

142 (82.1)

 Women

44 (21.6)

13 (41.9)

31 (17.9)

Age (years)

 <39.5

48 (23.5)

4 (12.9)

44 (25.4)

 ≥39.5

156 (76.5)

27 (87.1)

129 (74.6)

Initial radiation dose (Gy)

 <74.68

178 (87.3)

25 (80.6)

153 (88.4)

 ≥74.68

26 (12.7)

6 (19.4)

20 (11.6)

Recurrent stage

 I

13 (6.4)

0 (0)

13 (7.5)

 II

25 (12.3)

4 (12.9)

21 (12.1)

 III

78 (38.2)

13 (41.9)

65 (37.6)

 IV

88 (43.1)

14 (45.2)

74 (42.8)

Interval of recurrence (months)

 <25.5

73 (35.8)

9 (29.0)

64 (37.0)

 ≥25.5

131 (64.2)

22 (72.0)

109 (63.0)

CCRT during re-irradiation

 Yes

67 (32.8)

8 (25.8)

59 (34.1)

 No

137 (67.2)

23 (74.2)

114 (65.9)

Necrosis before re-irradiation

 Yes

41 (20.1)

12 (38.7)

29 (16.8)

 No

163 (79.9)

19 (61.3)

144 (83.2)

Re-irradiation dose (Gy)

 <67

135 (66.2)

18 (58.1)

117 (67.6)

 ≥67

69 (33.8)

13 (41.9)

56 (32.4)

Mean re-irradiation dose (Gy)

 <71.97

152 (74.5)

18 (58.1)

134 (77.5)

 ≥71.97

52 (25.5)

13 (41.9)

39 (22.5)

Re-irradiation fractionated dose (Gy)

 <2.3

197 (96.6)

30 (96.8)

167 (96.5)

 ≥2.3

7 (3.4)

1 (3.2)

6 (3.5)

Duration of re-irradiation (days)

 <49.5

173 (84.8)

23 (74.2)

150 (86.7)

 ≥49.5

31 (15.2)

8 (25.8)

23 (13.3)

Accumulated total GTV dose (Gy)

 <141.5

186 (91.2)

25 (80.6)

161 (93.1)

 ≥141.5

18 (8.8)

6 (19.4)

12 (6.9)

Recurrent tumor volume (cm3)

 <25.38

59 (28.9)

3 (9.7)

56 (32.4)

 ≥25.38

145 (71.1)

28 (90.3)

117 (67.6)

BMI

 <19.8

50 (24.5)

6 (19.4)

44 (25.4)

 ≥19.8

154 (75.5)

25 (80.6)

129 (74.6)

Necrosis

 Yes

77 (37.7)

31 (100)

46 (26.6)

 No

127 (62.2)

0 (0)

127 (73.4)

  1. All values are presented as the number of patients followed by percentage in the parentheses
  2. LNN lethal nasopharyngeal necrosis, CCRT concurrent chemoradiotherapy, GTV gross tumor volume, BMI body mass index